MEDICAL TRANSCRIPTION BLG CO - COM (MTBC)

CUSIP: 58464J105

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
1,212,824
Share change
+20,171
Total reported value
$1,237,000
Price per share
$1.02
Number of holders
8
Value change
+$20,388
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 58464J105?
CUSIP 58464J105 identifies MTBC - MEDICAL TRANSCRIPTION BLG CO - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) as of Q1 2016

As of 31 Mar 2016, MEDICAL TRANSCRIPTION BLG CO - COM (MTBC) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,212,824 shares. The largest 8 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., SILVERBACK ASSET MANAGEMENT LLC, JW Asset Management, LLC, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, UBS Group AG, THOMPSON DAVIS & CO., INC., and Tower Research Capital LLC (TRC). This page lists 8 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.